Legal & General Group PLC Atara Biotherapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $129,791 - $212,637	-92,051 Reduced 91.05%	9,047 $13,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $128,908 - $261,254	85,939 Added 566.92%	101,098 $162,000
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $182,448 - $355,773	-65,160 Reduced 81.13%	15,159 $43,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $6,745 - $20,663	2,367 Added 3.04%	80,319 $304,000
Q2 2022 Aug 22, 2022	BUY	$4.69 - $9.84 $8,878 - $18,627	1,893 Added 2.49%	77,952 $607,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $8,710 - $17,430	1,032 Added 1.38%	76,059 $707,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $253,428 - $342,903	17,240 Added 29.83%	75,027 $1.18 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $168,423 - $251,441	14,047 Added 32.11%	57,787 $1.04 Million
Q2 2021 Aug 12, 2021	SELL	$12.89 - $16.58 $18,432 - $23,709	-1,430 Reduced 3.17%	43,740 $680,000
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $136,388 - $201,854	-9,742 Reduced 17.74%	45,170 $649,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $225,640 - $467,130	17,809 Added 48.0%	54,912 $1.08 Million
Q3 2020 Nov 13, 2020	SELL	$11.92 - $15.87 $9,476 - $12,616	-795 Reduced 2.1%	37,103 $481,000
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $18,734 - $37,145	2,488 Added 7.03%	37,898 $552,000
Q1 2020 May 14, 2020	SELL	$5.69 - $17.78 $14,014 - $43,792	-2,463 Reduced 6.5%	35,410 $302,000
Q4 2019 Feb 13, 2020	BUY	$10.89 - $16.79 $184,247 - $284,070	16,919 Added 80.74%	37,873 $624,000
Q3 2019 Nov 13, 2019	BUY	$12.03 - $19.94 $39,157 - $64,904	3,255 Added 18.39%	20,954 $296,000
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $13,487 - $29,056	708 Added 4.17%	17,699 $356,000
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $5,168 - $7,596	182 Added 1.08%	16,991 $675,000
Q4 2018 Feb 15, 2019	BUY	$30.9 - $42.97 $30,374 - $42,239	983 Added 6.21%	16,809 $584,000
Q3 2018 Nov 20, 2018	BUY	$35.05 - $43.5 $329,154 - $408,508	9,391 Added 145.94%	15,826 $655,000
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $8,014 - $11,730	228 Added 3.67%	6,435 $237,000
Q1 2018 May 17, 2018	SELL	$18.0 - $48.35 $2,142 - $5,753	-119 Reduced 1.88%	6,207 $243,000
Q4 2017 Feb 13, 2018	BUY	$13.2 - $18.1 $83,503 - $114,500	6,326	6,326 $110,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.34B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account